Results for novavax janssen

Add to feed Create your own feed


‘Desperately waiting’: The Australians who need Novavax for medical reasons | @Dana_Adele 

Australia APPROVES the jab some anti-vaxxers have been waiting for: Breakthrough Novavax Covid-19 vaccine gets the green-light - here's how it's different

Novavax Covid vaccine: what is it and will it make a difference?

Australia adds Novavax vaccine and antivirals from Pfizer, MSD to COVID-19 arsenal

Swiss teenagers, aged 12 to 15, and people who received initial doses of Janssen vector viral vaccine are advised to take a mRNA booster jab.

Waiting for Novavax? 💉 You're in luck, because the protein-based COVID vaccine has finally been approved for use in Australia. More on this story:

Australia adds Novavax vaccine and antivirals from Pfizer, MSD to COVID-19 arsenal

$NVAX - Novavax's Long-Term Prospects Are Questionable. #trading  #finance  #stockmarket 

$NVAX (+1.8% pre) Novavax’s COVID-19 vaccine gains momentum with Australia approval - Fortune


Most relevant

BREAKING: Novavax is working on a vaccine to protect against new 'Omicron' coronavirus variant

Pfizer, Biontech, Novavax, Moderna shares plunge to session lows after U.S. backs waiving patent protections on Covid vaccines

tweet picture

Breaking News: Novavax’s Covid-19 vaccine demonstrated an overall efficacy of 90.4%, on par with the vaccines made by Pfizer-BioNTech and Moderna, in a new trial. But with the U.S. awash in other options, it might be needed more elsewhere.

Covid-19 vaccine Novavax - of which the British government has ordered 60 million doses - proves 89.3% effective in large-scale UK trials

Janssen single-dose Covid vaccine approved for use by UK medicines regulator, and will be available later this year

Big news: The JNJ vaccine results of 44,000 Phase 3 trial, a single dose. Overall 66% efficacy, with the contrast of 72% in US but 57% in South Africa, confirming immune escape/resistance of B.1.351 variant seen by Novavax

tweet picture

If a COVID-19 vaccine is made available, will you get one? RETWEET = YES FAVOURITE = NO The federal government has reached agreements with Novavax and Johnson & Johnson to secure millions of doses of COVID-19 vaccine candidates. More:

tweet picture

Wall Street Week... Koss $KOSS: +1,740% Blockbuster $BLIAQ: +1,233% Dogecoin $DOGE: +513% GameStop $GME: +405% AMC $AMC: +280% Express $EXPR: +234% Novavax $NVAX: +74% Volatility Index $VIX: +51% --- Nasdaq 100 $QQQ: -3.3% S&P 500 $SPY: -3.3% Apple $AAPL: -5.2% Tesla $TSLA: -6.3%

Breaking: Novavax Covid vaccine shows 89% efficacy in UK trials. Half the cases on the trial were the new ‘Kent’variant so this is first vaccine to show it is effective against the new more contagious variant

One of the frontrunners in the race to develop a coronavirus vaccine, Novavax Inc., will receive $1.6 billion from the govt’s Operation Warp Speed program. Will allow the company to conduct advanced human studies.